IL-10 and its homologs: Important immune mediators and emerging immunotherapeutic agents

Trends in Immunology

Volumn 22, Issue 8, 2001, Pages 414-417

  Volk, Hans Dieter ^a   Asadullah, Khusru ^b   Gallagher, Grant ^c   Sabat, Robert ^b   Grütz, Gerald ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIFFERENTIATION ANTIGEN; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 22; MELANOMA DIFFERENTIATION ANTIGEN 7; PROTEIN ANDREA KNAPPE 155; RECOMBINANT INTERLEUKIN 10; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ACTIVITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE LOCATION; GENE THERAPY; HUMAN; IMMUNOPATHOLOGY; IMMUNOREGULATION; KERATINOCYTE; NONHUMAN; PROTEIN EXPRESSION; RELAPSE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; HUMANS; INTERLEUKIN-10; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0035424124     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)01985-8     Document Type: Conference Paper

References (2)

1. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
2. Cloning, expression and initial characterisation of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)